Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Ltd | Sector: Pharmaceuticals | ISIN: INE806D01016

Trade

Corporate Actions

07 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2023

12:00 AM

Results

View Details

07 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Nov , 2022

12:00 AM

Results

View Details

09 Sep , 2022

12:00 AM

AGM

Announcement date: 09 Sep , 2022

View Details

06 Aug , 2022

12:00 AM

Results

View Details

06 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

09 Sep , 2022

12:00 AM

BookCloser

View Details

Ishita Drugs & Industries Ltd News and Update

Reliance stock price up by more than 4% today

1 day ago |
4:13 PM

Company's stock rises after it announces that its financial services business will be demerged from Reliance Industries.

Markets in Green

1 day ago |
4:13 PM

Britannia fixes record date for interim dividend for FY 2022-23

IIFL News Service |
29 March, 2023 |
4:11 PM

Reliance Industries completes acquisition of Sintex Textiles

29 March, 2023 |
4:10 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	983.10	90.94	2,35,878.62	486.73	1.02	4,549.90	108.48
Dr Reddys Laboratories Ltd	4,624.15	32.61	76,960.95	324.60	0.65	3,879.60	1,156.21
Divis Laboratories Ltd	2,826.00	31.62	75,014.78	310.90	1.06	1,689.83	454.85
Cipla Ltd	900.65	26.27	72,696.02	678.52	0.55	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,543.40	49.61	52,030.91	229.00	1.56	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Ishita Drugs & Industries Ltd

Jagdish Agrawal
Managing Director

Govind Gupta
Independent Director

Abha Agrawal
Director

Niranjan Agrawal
Independent Director

Arvind Sapkal
Independent Director

Srushti Pandya
Company Sec. & Compli. Officer

Summary

Summary Info Not Found

Reports by Ishita Drugs & Industries Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Ishita Drugs & Industries Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Ishita Drugs & Industries Ltd

KEY RATIOS

Corporate Actions

SHAREHOLDING SNAPSHOT 01 April , 2023 | 05:14 PM

Knowledge Center

Ishita Drugs & Industries Ltd News and Update

FINANCIALS

Select Period:

QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

PEER COMPARISON

MORE ABOUT Ishita Drugs & Industries Ltd

Jagdish Agrawal

Govind Gupta

Abha Agrawal

Niranjan Agrawal

Arvind Sapkal

Srushti Pandya

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

SHAREHOLDING SNAPSHOT
01 April , 2023 | 05:14 PM